Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Videos

Understanding Indications, Tailoring Therapy Options for CLL Patients

logoBenyam Muluneh, PharmD, assistant professor, UNC Eshelman School of Pharmacy, and Katie Buhlinger, PharmD, CPP, clinical pharmacist practitioner, UNC Medical Center, discuss the benefits and complications associated with ibrutinib treatment for patients with CLL.

 

Advertisement

Advertisement

Advertisement